Pierre Robin Sequence Outcome Assessment Multi Institutional Study

ClinicalTrials.gov ID: NCT02432638

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02432638. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 10:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pierre Robin Sequence Outcome Assessment Multi Institutional Study (PROMIS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this prospective, multi-center, longitudinal study is to assess clinical outcomes related to the surgical treatment of PRS ( Pierre Robin Sequence) by MDO (Mandibular distraction osteogenesis). This study aims to develop a scoring system to determine success and complication rate pre and post MDO.

Study identification

NCT ID: NCT02432638
Recruitment status: Withdrawn
Study type: Observational
Phase: Not listed
Lead sponsor: NYU Langone Health; Other
Enrollment: Not listed

Conditions and interventions

Conditions

Pierre Robin Sequence

Interventions

Not listed

Eligibility (public fields only)

Age range: 1 Day to 6 Months
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2015 (Type not available)
Primary completion: Oct 27, 2017 (Actual)
Completion: Oct 27, 2017 (Actual)
Last update posted: Nov 22, 2017

2015 – 2017

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
NYU School of Medicine	New York	New York	10010	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02432638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 22, 2017 · Synced Nov 13, 2026